NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/01/2025
Back to search
Official data from USPTO
LIBERVANT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
04/01/2025
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
01/07/2022
Registration date
04/01/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/01/2025
Last transaction
04/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/29/2024
First use in commerce
04/29/2024
Drawing code
3
Owner type
03
Owner location
Warren, NJ, US
Examiner
GOODWIN, KATRINA JOYE
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "LIBERVANT" in blue font to the left of two overlapping triangles in the colors orange and yellow.
Holders and representatives
Holders
Aquestive Therapeutics, Inc.
Representatives
Carrie Webb Olson DAY PITNEY LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of neurologicalcardiopulmonaryviralmetabolicendocrinemusculoskeletalgenitourinarygastrointestinaloncologicalautoimmuneinflammatorypainrespiratoryhormonalcentral nervous systempsychiatric related diseases and disorders; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of epilepsyanxiety disordersseizure disorderssleep disordersinsomniaalcoholopiate and benzodiazepine withdrawal syndromemuscle spasmspsychiatric disorders; pharmaceutical preparationsanticonvulsantsanti seizure medicationspsychotropicsbenzodiazepinessedativesmuscle relaxantsmood stabilizing medications
Publications
History of USPTO decisions and trademark events.
43 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/01/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/07/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/07/2025
DOCK
ASSIGNED TO EXAMINER
03/07/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/15/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/14/2024
IUAF
USE AMENDMENT FILED
09/13/2024
EISU
TEAS STATEMENT OF USE RECEIVED
09/13/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/26/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/26/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/26/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/26/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/15/2024
EX4G
SOU EXTENSION 4 GRANTED
05/14/2024
EXT4
SOU EXTENSION 4 FILED
05/14/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/14/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/15/2023
EX3G
SOU EXTENSION 3 GRANTED
11/13/2023
EXT3
SOU EXTENSION 3 FILED
11/13/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/13/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/01/2023
EX2G
SOU EXTENSION 2 GRANTED
05/30/2023
EXT2
SOU EXTENSION 2 FILED
05/30/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/30/2023
DOCK
ASSIGNED TO EXAMINER
02/13/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/30/2022
EX1G
SOU EXTENSION 1 GRANTED
11/28/2022
EXT1
SOU EXTENSION 1 FILED
11/28/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/28/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/25/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/25/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/25/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/25/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/21/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2022
PUBO
PUBLISHED FOR OPPOSITION
04/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/22/2022
DOCK
ASSIGNED TO EXAMINER
03/16/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/13/2022
NWAP
NEW APPLICATION ENTERED
01/11/2022
Continuous trademark protection
Get notified about every new filing that threatens LIBERVANT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.